Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 22136096)

1.

Co-morbid disruptive behavior disorder and aggression predict functional outcomes and differential response to risperidone versus divalproex in pharmacotherapy for pediatric bipolar disorder.

West AE, Weinstein SM, Celio CI, Henry D, Pavuluri MN.

J Child Adolesc Psychopharmacol. 2011 Dec;21(6):545-53. doi: 10.1089/cap.2010.0140. Epub 2011 Dec 2.

2.
3.

Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.

Vitiello B, Riddle MA, Yenokyan G, Axelson DA, Wagner KD, Joshi P, Walkup JT, Luby J, Birmaher B, Ryan ND, Emslie G, Robb A, Tillman R.

J Am Acad Child Adolesc Psychiatry. 2012 Sep;51(9):867-78. doi: 10.1016/j.jaac.2012.07.001. Epub 2012 Jul 31.

4.

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.

Pavuluri MN, Henry DB, Findling RL, Parnes S, Carbray JA, Mohammed T, Janicak PG, Sweeney JA.

Bipolar Disord. 2010 Sep;12(6):593-605. doi: 10.1111/j.1399-5618.2010.00850.x.

5.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
6.

A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.

Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P.

Arch Gen Psychiatry. 2012 May;69(5):515-28. doi: 10.1001/archgenpsychiatry.2011.1508. Epub 2012 Jan 2.

7.

Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.

Blader JC, Schooler NR, Jensen PS, Pliszka SR, Kafantaris V.

Am J Psychiatry. 2009 Dec;166(12):1392-401. doi: 10.1176/appi.ajp.2009.09020233. Epub 2009 Nov 2.

8.
9.

Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.

MacMillan CM, Withney JE, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez-Heydrich JM.

J Psychiatr Pract. 2008 May;14(3):160-9. doi: 10.1097/01.pra.0000320115.38434.16.

PMID:
18520785
10.

A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities.

Buitelaar JK, van der Gaag RJ, Cohen-Kettenis P, Melman CT.

J Clin Psychiatry. 2001 Apr;62(4):239-48.

PMID:
11379837
11.

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.

Pavuluri MN, Passarotti AM, Lu LH, Carbray JA, Sweeney JA.

Psychiatry Res. 2011 Jul 30;193(1):28-37. doi: 10.1016/j.pscychresns.2011.01.005. Epub 2011 May 17.

12.

Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder.

Saxena K, Howe M, Simeonova D, Steiner H, Chang K.

J Child Adolesc Psychopharmacol. 2006 Jun;16(3):252-9.

PMID:
16768633
14.
15.

Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.

Houston JP, Tohen M, Degenhardt EK, Jamal HH, Liu LL, Ketter TA.

J Clin Psychiatry. 2009 Nov;70(11):1540-7. doi: 10.4088/JCP.08m04895yel. Epub 2009 Sep 22. Erratum in: J Clin Psychiatry. 2010 Jan;71(1):93. J Clin Psychiatry. 2011 Aug;72(8):1157.

PMID:
19778495
16.

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.

Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL; Risperidone Disruptive Behavior Study Group.

Am J Psychiatry. 2002 Aug;159(8):1337-46.

PMID:
12153826
17.

Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.

Pavuluri MN, Passarotti AM, Fitzgerald JM, Wegbreit E, Sweeney JA.

J Am Acad Child Adolesc Psychiatry. 2012 Feb;51(2):157-170.e5. doi: 10.1016/j.jaac.2011.10.019. Epub 2011 Dec 23.

18.

Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania.

Pavuluri MN, Ellis JA, Wegbreit E, Passarotti AM, Stevens MC.

Behav Brain Res. 2012 Jan 15;226(2):493-503. doi: 10.1016/j.bbr.2011.10.003. Epub 2011 Oct 8.

19.
20.

Child Mania Rating Scale-Parent Version: a valid measure of symptom change due to pharmacotherapy.

West AE, Celio CI, Henry DB, Pavuluri MN.

J Affect Disord. 2011 Jan;128(1-2):112-9. doi: 10.1016/j.jad.2010.06.013. Epub 2010 Sep 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk